• head_banner_01

Tirzepatide APl

Product Name : Tirzepatide API
CAS No.:  2023788-19-2
Purity: ≥98%
Appearance: White powder

Tirzepatide is a synthetic linear peptide consisting of 39 amino acids, with the lysine residue at position 20 conjugated to a C20 fatty diacid moiety via a linker. Its molecular formula is C₂₂₅H₃₄₈N₄₈O₆₈, and its molecular weight is approximately 4,813.53 Da. It acts as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor, representing a first-in-class therapeutic agent.

As an active pharmaceutical ingredient (API), tirzepatide is the core biologically active component of the finished pharmaceutical product. When purchasing tirzepatide API, buyers must ensure that it meets stringent pharmaceutical-grade quality standards, including high purity (typically ≥98% as determined by high-performance liquid chromatography (HPLC)), low residual solvent content, controlled endotoxin levels, and comprehensive identity verification using mass spectrometry and amino acid analysis.

Tirzepatide-Gentolex Group Tirzepatide 替尔泊肽(DMF) was produced use the same chemical synthesis methods with the RLD company Lilly. Tirzepatide-Gentolex Group has fewer impurities and lower level of impurity than MOUNJARO-Lilly US, and has no unknown impurities detected above 0.10%. At the same time, through optimizing purification and salting processes, Tirzepatide-Gentolex Group has a solubility of >50mg/mL in non-buffered water, making it more convenient for formulation and compounding.
Gentolex Group has completed the full process development and validation of the chemical synthesis of Tirzepatide.

Tirzepatide api_

 


Post time: Nov-20-2026